Literature DB >> 11796599

Investigation of role of nitric oxide in protection from Bordetella pertussis respiratory challenge.

C Canthaboo1, D Xing, X Q Wei, M J Corbel.   

Abstract

The mechanism whereby whole-cell pertussis vaccines (WCV) confer protection against Bordetella pertussis is still not fully understood. We have previously reported that macrophage activation produced by vaccination with WCV is associated with induction of NO synthesis by macrophages in response to in vitro stimulation with B. pertussis antigens. To determine whether NO production is an effector of protection or simply a marker of activation, the susceptibility of inducible nitric oxide synthase (type II, iNOS) knockout mice to infection with B. pertussis was examined. We showed that iNOS knockout mice were more susceptible to B. pertussis respiratory challenge than wild-type mice. iNOS-deficient mice also developed a less effective protective response than wild-type mice after the same immunization with WCV. This suggests that NO plays an important role in effecting protection against B. pertussis challenge.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11796599      PMCID: PMC127720          DOI: 10.1128/IAI.70.2.679-684.2002

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  21 in total

1.  Effects of nitric oxide on the induction and differentiation of Th1 cells.

Authors:  W Niedbala; X Q Wei; D Piedrafita; D Xu; F Y Liew
Journal:  Eur J Immunol       Date:  1999-08       Impact factor: 5.532

2.  Nitric oxide regulates Th1 cell development through the inhibition of IL-12 synthesis by macrophages.

Authors:  F P Huang; W Niedbala; X Q Wei; D Xu; G J Feng; J H Robinson; C Lam; F Y Liew
Journal:  Eur J Immunol       Date:  1998-12       Impact factor: 5.532

3.  Septic arthritis following Staphylococcus aureus infection in mice lacking inducible nitric oxide synthase.

Authors:  I B McInnes; B Leung; X Q Wei; C C Gemmell; F Y Liew
Journal:  J Immunol       Date:  1998-01-01       Impact factor: 5.422

4.  Mice lacking inducible nitric-oxide synthase are more susceptible to herpes simplex virus infection despite enhanced Th1 cell responses.

Authors:  A MacLean; X Q Wei; F P Huang; U A Al-Alem; W L Chan; F Y Liew
Journal:  J Gen Virol       Date:  1998-04       Impact factor: 3.891

5.  Nitric oxide induction in murine macrophages and spleen cells by whole-cell Bordetella pertussis vaccine.

Authors:  D K Xing; C Canthaboo; M J Corbel
Journal:  Vaccine       Date:  1998-01       Impact factor: 3.641

6.  Effect of pertussis toxin on the induction of nitric oxide synthesis in murine macrophages and on protection in vivo.

Authors:  D K Xing; C Canthaboo; M J Corbel
Journal:  Vaccine       Date:  2000-04-14       Impact factor: 3.641

7.  An aerosol challenge model of Bordetella pertussis infection as a potential bioassay for acellular pertussis vaccines.

Authors:  D K Xing; R G Das; L Williams; C Canthaboo; J Tremmil; M J Corbel
Journal:  Vaccine       Date:  1999-02-12       Impact factor: 3.641

8.  A controlled trial of two acellular vaccines and one whole-cell vaccine against pertussis. Progetto Pertosse Working Group.

Authors:  D Greco; S Salmaso; P Mastrantonio; M Giuliano; A E Tozzi; A Anemona; M L Ciofi degli Atti; A Giammanco; P Panei; W C Blackwelder; D L Klein; S G Wassilak
Journal:  N Engl J Med       Date:  1996-02-08       Impact factor: 91.245

9.  Altered immune responses in mice lacking inducible nitric oxide synthase.

Authors:  X Q Wei; I G Charles; A Smith; J Ure; G J Feng; F P Huang; D Xu; W Muller; S Moncada; F Y Liew
Journal:  Nature       Date:  1995-06-01       Impact factor: 49.962

10.  In vitro and in vivo induction of nitric oxide by murine macrophages stimulated with Bordetella pertussis.

Authors:  D Torre; G Ferrario; G Bonetta; L Perversi; F Speranza
Journal:  FEMS Immunol Med Microbiol       Date:  1996-02
View more
  9 in total

1.  Bordetella avium causes induction of apoptosis and nitric oxide synthase in turkey tracheal explant cultures.

Authors:  David M Miyamoto; Kristin Ruff; Nathan M Beach; Stephanie B Stockwell; Angella Dorsey-Oresto; Isaac Masters; Louise M Temple
Journal:  Microbes Infect       Date:  2011-05-12       Impact factor: 2.700

2.  A critical role for the TLR signaling adapter Mal in alveolar macrophage-mediated protection against Bordetella pertussis.

Authors:  N J Bernard; C M Finlay; G M Tannahill; J P Cassidy; L A O'Neill; K H G Mills
Journal:  Mucosal Immunol       Date:  2014-12-17       Impact factor: 7.313

3.  A CpG-containing oligodeoxynucleotide adjuvant for acellular pertussis vaccine improves the protective response against Bordetella pertussis.

Authors:  Catpagavalli Asokanathan; Michael Corbel; Dorothy Xing
Journal:  Hum Vaccin Immunother       Date:  2013-01-04       Impact factor: 3.452

4.  Effect of different forms of adenylate cyclase toxin of Bordetella pertussis on protection afforded by an acellular pertussis vaccine in a murine model.

Authors:  Gordon Y C Cheung; Dorothy Xing; Sandra Prior; Michael J Corbel; Roger Parton; John G Coote
Journal:  Infect Immun       Date:  2006-09-18       Impact factor: 3.441

5.  Bordetella bronchiseptica responses to physiological reactive nitrogen and oxygen stresses.

Authors:  Anders Omsland; Katrina M Miranda; Richard L Friedman; Scott Boitano
Journal:  FEMS Microbiol Lett       Date:  2008-05-06       Impact factor: 2.742

6.  c-di-GMP enhances protective innate immunity in a murine model of pertussis.

Authors:  Shokrollah Elahi; Jill Van Kessel; Tedele G Kiros; Stacy Strom; Yoshihiro Hayakawa; Mamoru Hyodo; Lorne A Babiuk; Volker Gerdts
Journal:  PLoS One       Date:  2014-10-15       Impact factor: 3.240

7.  Macrophage Activation Assays to Evaluate the Immunostimulatory Capacity of Avibacterium paragallinarum in A Multivalent Poultry Vaccine.

Authors:  Robin H G A van den Biggelaar; Willem van Eden; Victor P M G Rutten; Christine A Jansen
Journal:  Vaccines (Basel)       Date:  2020-11-10

8.  Assessment of In Vitro Immunostimulatory Activity of an Adjuvanted Whole-Cell Inactivated Neisseria gonorrhoeae Microparticle Vaccine Formulation.

Authors:  Priyal Bagwe; Lotika Bajaj; Rikhav P Gala; Martin J D'Souza; Susu M Zughaier
Journal:  Vaccines (Basel)       Date:  2022-06-21

9.  The role of nitric oxide in mycobacterial infections.

Authors:  Chul-Su Yang; Jae-Min Yuk; Eun-Kyeong Jo
Journal:  Immune Netw       Date:  2009-04-30       Impact factor: 6.303

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.